drugset / Trial / NCT06273852
A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
NaSingle-groupOpen-labelBasic science
Summary
This is a multi-center, single arm, open-label, localized pharmacodynamic biomarker Phase 0 trial designed to study the biological effects within the tumor microenvironment of PBA-0405 when administered intratumorally in microdose quantities via the CIVO device.
Timeline
- Start
- 2024-04-29
- Primary completion
- 2025-03-15
- Completion
- 2025-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PBA-0405 | Unknown | 0.0083 ml | Other |